A recent study led by researchers in Texas A&M University's department of nutrition and food science shows how a novel regulatory mechanism serves as an important biomarker for the development of diabetes, as well as a potential ...
Dec 14, 2018
0
105
Giving overweight or obese patients a gut hormone that suppresses appetite leads to clinically beneficial weight loss as well as reduced blood pressure and cholesterol levels, finds a study published in the British Medical ...
Jan 10, 2012
1
0
(Medical Xpress)—Working with mice and human blood and liver samples, scientists from the Johns Hopkins Children's Center have identified a previously unsuspected liver hormone as a critical player in the development of ...
Apr 3, 2014
0
0
(HealthDay) -- Drinking a diet soda before a glucose load is associated with increased glucagon-like peptide 1 (GLP-1) secretion in individuals with type 1 diabetes and healthy controls, but not in those with type 2 diabetes, ...
Mar 22, 2012
0
0
Many diabetes patients do not only have problems with their insulin, but also with the release of the hormone glucagon. Researchers at Uppsala University have now discovered a regulation mechanism which could provide an opportunity ...
Apr 26, 2019
0
27
Researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine and colleagues have discovered a new protein that may play a critical role in how the human body regulates blood sugar levels. Reporting ...
Jan 4, 2012
0
0
(HealthDay)—Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published ...
Jun 25, 2014
0
0
(Medical Xpress)—New research has shown the promising potential of a glucose-regulating drug to improve the condition of arteries for diabetes sufferers, possibly protecting them against heart attack or stroke.
Sep 23, 2013
0
0
A group of researchers from the Helmholtz Munich Institute for Diabetes and Cancer (IDC) have unraveled a new strategy to alter glucagon receptor signaling in the liver by changing its intracellular trafficking. Glucagon ...
Oct 18, 2022
0
56
Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at Vanderbilt ...
Feb 21, 2020
0
6
